Effect of tetrahydroaminoacridine on sleep in healthy subjects

Biological Psychiatry

Volumn 39, Issue 9, 1996, Pages 796-802

  Riemann, Dieter ^a   Lis, Stefanie ^a   Fritsch Montero, Rosemarie ^a   Meier, Thomas ^a   Krieger, Stefan ^a   Hohagen, Fritz ^a   Berger, Mathias ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cholinergic neurotransmission; REM latency; Tacrine

Indexed keywords

TACRINE;

ADULT; ARTICLE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REM SLEEP; SLEEP;

EID: 0029978939     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00224-3     Document Type: Article

References (26)

1. Berger M, Lund R, Bronisch T, von Zerssen D (1983): REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res 10:113-123.
2. Berkowitz A, Sutton L, Janowsky D, Gillin JC (1989): Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers. Psychiatry Res 33:113-119.
3. Chatellier G, Lacomblez L (1990): Tacrine (tetrahydroaminoacridine: THA) and lecithin in senile dementia of the Alzheimer type: A multicenter trial. Br Med J 300:495-499.
4. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J (1992): A controlled trial of tacrine in Alzheimer's disease. JAMA 268:2523-2529.
5. Fitten LJ, Perryman KM, Gross PL, et al (1990): Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: A double-blind study. Am J Psychiatry 147:239-242.
6. Gauthier S, Bouchard R, Lamontagne A, et al (1990): Tetrahydroaminoacridine lecithin combination treatment in patients with intermediate-state Alzheimer's disease. N Engl J Med 322:1272-1276.
7. Görtelmeyer R (1986): Schlaffragebogen A. In CIPS (ed), Internationale Skalen für Psychiatrie. Weinheim: Beltz.
8. Greenhouse SW, Geisser S (1959): On methods in the analysis of profile data. Psychometrika 24:95-110.
9. Hobson JA, McCarley RW, Wyzinski PW (1975): Sleep cycle oscillation: Reciprocal discharge by two brain stem neuronal groups. Science 189:55-58.
10. Hobson JA, Steriade M (1986): Neuronal basis of behavioral state control. In Mountcastle VB, Bloom FE, Geiger SR (eds), Handbook of Physiology, vol. 4: Intrinsic Regulatory Systems of the Brain. Bethesda, MD: American Physiological Society, pp 701-823.
11. Hohagen F, Spiegel R, Holzhauer M, Riemann D, Berger M (1993): The influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects. Neuropsychopharmacology 9:225-232.
12. Holsboer-Traxler E, Hatzinand M, Stohler R, et al (1993): Effects of the novel acetylcholinesterase inhibitor SDZ-ENA 713 on sleep in man. Neuropsychopharmacology 8:87-92.
13. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI (1994): A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271:985-991.
14. McGeer PL, McGeer EG, Suzuki J, et al (1984): Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology 34:741-745.
15. Petit D, Montplaisir J, Loorain D, Gauthier S (1993): THA does not affect sleep or EEG spectral power in Alzheimer's disease. Biol Psychiatry 33:753-754.
16. Rechtschaffen A, Kales A (1968): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. USPHS Publication No. 204. Washington, DC: US Government Printing Office.
17. Riemann D, Gann H, Dressing H, Müller WE, Aldenhoff JB (1994a): The influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psychiatry Res 51:253-267.
18. Riemann D, Hohagen F, Gann H, Bohus M, Löw H, Wark HJ, Olbrich R, Müller WE, Berger M (1994b): Muscarinic supersensitivity in schizophrenia: Evidence from sleep recordings. J Psychiatr Res 28:195-210.
19. Riemann D, Joy D, Höchli D, Lauer C, Zulley J, Berger M (1988): The influence of the cholinergic agonist RS 86 on normal sleep with regard to sex and age. Psychiatry Res 24:137-147.
20. Sitaram N, Mendelson WB, Wyatt RJ, Gillin JC (1977): The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep. Brain Res 122:562-567.
21. Sitaram N, Moore AM, Gillin JC (1978a): Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 274:490-492.
22. Sitaram N, Moore AM, Gillin JC (1978b): Induction and resetting of REM sleep rhythm in normal man by arecoline blockade by scopolamine. Sleep 1:83-90.
23. Sitaram N, Wyatt RJ, Dawson S, Gillin JC (1976): REM sleep induction by physostigmine infusion during sleep. Science 191:1281-1283.
24. Spiegel R (1984): Effects of RS 86, an orally active cholinergic agonist, on sleep in man. Psychiatry Res 11:1-13.
25. Steriade M, McCarley RW (1990): Brain Stem Control of Wakefulness and Sleep. New York: Plenum Press.
26. Summers WK, Majovski LV, March GM, et al (1986): Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 20:1241-1245.